Related references
Note: Only part of the references are listed.TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding
Penka S. Petrova et al.
CLINICAL CANCER RESEARCH (2017)
Cancer immunotherapy targeting the CD47/SIRPα axis
Kipp Weiskopf
EUROPEAN JOURNAL OF CANCER (2017)
Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies
E. C. Pietsch et al.
BLOOD CANCER JOURNAL (2017)
A review of new agents evaluated against pediatric acute lymphoblastic leukemia by the Pediatric Preclinical Testing Program
L. Jones et al.
LEUKEMIA (2016)
Honokiol targets mitochondria to halt cancer progression and metastasis
Jing Pan et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2016)
α-Integrin expression and function modulates presentation of cell surface calreticulin
C-C Liu et al.
CELL DEATH & DISEASE (2016)
Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy
Lin Mei et al.
BLOOD REVIEWS (2015)
Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
Michele Cioffi et al.
CLINICAL CANCER RESEARCH (2015)
CD47 blockade triggers T cell-mediated destruction of immunogenic tumors
Xiaojuan Liu et al.
NATURE MEDICINE (2015)
Treatment of Pediatric Acute Lymphoblastic Leukemia
Stacy L. Cooper et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2015)
CD47 Agonist Peptides Induce Programmed Cell Death in Refractory Chronic Lymphocytic Leukemia B Cells via PLCγ1 Activation: Evidence from Mice and Humans
Ana-Carolina Martinez-Torres et al.
PLOS MEDICINE (2015)
Honokiol Induces Cell Cycle Arrest and Apoptosis Via Inhibiting Class I Histone Deacetylases in Acute Myeloid Leukemia
Hai-Ying Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
Jie Liu et al.
PLOS ONE (2015)
CD47 does not mediate amyloid-β(1-42) protofibril-stimulated microglial cytokine release
Sanjib Karki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
A CD47-blocking TRAIL fusion protein with dual pro-phagocytic and pro-apoptotic anticancer activity
Valerie R. Wiersma et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
CD47-dependent immunomodulatory and angiogenic activities of extracellular vesicles produced by T cells
Sukhbir Kaur et al.
MATRIX BIOLOGY (2014)
CD47-Independent Effects Mediated by the TSP-Derived 4N1K Peptide
Pascal Leclair et al.
PLOS ONE (2014)
Noxa and cancer therapy Tuning up the mitochondrial death machinery in response to chemotherapy
Marie-Christine Albert et al.
MOLECULAR & CELLULAR ONCOLOGY (2014)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest
E. Sick et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Honokiol: A Novel Natural Agent for Cancer Prevention and Therapy
S. Arora et al.
CURRENT MOLECULAR MEDICINE (2012)
The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications
Mark P. Chao et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Stephen B. Willingham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A new disulfide-linked dimer of a single-chain antibody fragment against human CD47 induces apoptosis in lymphoid malignant cells via the hypoxia inducible factor-1α pathway
Morihiko Sagawa et al.
CANCER SCIENCE (2011)
Heparan Sulfate Modification of the Transmembrane Receptor CD47 Is Necessary for Inhibition of T Cell Receptor Signaling by Thrombospondin-1
Sukhbir Kaur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Late Effects of Childhood Leukemia Therapy
Joy M. Fulbright et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2011)
Mitochondria and cell death: outer membrane permeabilization and beyond
Stephen W. G. Tait et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Honokiol, a Multifunctional Antiangiogenic and Antitumor Agent
Levi E. Fried et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Ravindra Majeti et al.
CELL (2009)
Caspase-independent type III programmed cell death in chronic lymphocytic leukemia: the key role of the F-actin cytoskeleton
Sandrine Barbier et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Radioprotection in Normal Tissue and Delayed Tumor Growth by Blockade of CD47 Signaling
Justin B. Maxhimer et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Death by a thousand cuts: Granzyme pathways of programmed cell death
Dipanjan Chowdhury et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer
Hongyu Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Noxa: at the tip of the balance between life and death
C. Ploner et al.
ONCOGENE (2008)
Drp1 mediates caspase-independent type III cell death in normal and leukemic cells
Marlene Bras et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore
Ling Li et al.
CANCER RESEARCH (2007)
Role for CD47-SIRPα signaling in xenograft rejection by macrophages
Kentaro Ide et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1
Jeff S. Isenberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Heat shock induces apoptosis independently of any known initiator caspase-activating complex
Rania S. Milleron et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Life in the balance: how BH3-only proteins induce apoptosis
SN Willis et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis
K Ishitsuka et al.
BLOOD (2005)
The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells
TE Battle et al.
BLOOD (2005)
A bivalent single-chain Fv fragment against CD47 induces apoptosis for leukemic cells
Y Kikuchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
CD47 mediates killing of breast tumor cells via Gi-dependent inhibition of protein kinase A
PP Manna et al.
CANCER RESEARCH (2004)
Post-transcriptional regulation of glucose transporter-1 by an AU-rich element in the 3′UTR and by hnRNP A2
ME Griffin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
CD47 and the 19 kDa interacting protein-3 (BNIP3) in T cell apoptosis
L Lamy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The mechanism of CD47-dependent killing of T cells:: Heterotrimeric Gi-dependent inhibition of protein kinase A
PP Manna et al.
JOURNAL OF IMMUNOLOGY (2003)
Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization
W Mateo et al.
BLOOD (2002)
Apoptosis: A link between cancer genetics and chemotherapy
RW Johnstone et al.
CELL (2002)
Normal ligand binding and signaling by CD47 (integrin-associated protein) requires a long range disulfide bond between the extracellular and membrane-spanning domains
RA Rebres et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
